Operating Income (Loss) of CLOVER HEALTH INVESTMENTS, CORP. /DE from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CLOVER HEALTH INVESTMENTS, CORP. /DE quarterly and annual Operating Income (Loss) in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE Operating Income (Loss) for the quarter ending 31 Dec 2025 was $49,319,000, a 130% decline year-over-year.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE Operating Income (Loss) for the twelve months ending 31 Dec 2025 was $85,529,000, a 87% decline year-over-year.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE annual Operating Income (Loss) for 2025 was $85,529,000, a 87% decline from 2024.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE annual Operating Income (Loss) for 2024 was $45,749,000, a 78% increase from 2023.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE annual Operating Income (Loss) for 2023 was $205,329,000, a 28% increase from 2022.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

CLOVER HEALTH INVESTMENTS, CORP. /DE Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $85,529,000 $49,319,000 -$27,871,000 -130% 01 Oct 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $57,658,000 $24,377,000 -$15,592,000 -177% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $42,066,000 $10,559,000 -$17,746,000 -247% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $24,320,000 $1,274,000 +$21,429,000 +94% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $45,749,000 $21,448,000 +$41,685,000 +66% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $87,434,000 $8,785,000 +$24,831,000 +74% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $112,265,000 $7,187,000 +$36,069,000 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 $148,334,000 $22,703,000 +$56,995,000 +72% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $205,329,000 $63,133,000 -$40,773,000 -182% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2026 2025 FY
Q3 2023 $164,556,000 $33,616,000 +$40,480,000 +55% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $205,036,000 $28,882,000 +$73,845,000 +72% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $278,881,000 $79,698,000 +$7,783,000 +8.9% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $286,664,000 $22,360,000 +$164,429,000 +88% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
Q3 2022 $451,093,000 $74,096,000 +$75,157,000 +50% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $526,250,000 $102,727,000 +$79,135,000 +44% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $605,385,000 $87,481,000 +$31,607,000 +27% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $636,992,000 $186,789,000 -$119,160,000 -176% 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q3 2021 $517,832,000 $149,253,000 -$127,635,000 -590% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $390,197,000 $181,862,000 -$205,032,000 -885% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $185,165,000 $119,088,000 -$92,458,000 -347% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $92,707,000 $67,629,000 -$67,611,369 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 $25,095,631 $21,618,000 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $23,170,000 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $26,630,000 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $17,631* 18 Oct 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY

CLOVER HEALTH INVESTMENTS, CORP. /DE Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $85,529,000 -$39,780,000 -87% 01 Jan 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
2024 $45,749,000 +$159,580,000 +78% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
2023 $205,329,000 +$81,335,000 +28% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2026 2025 FY
2022 $286,664,000 +$350,328,000 +55% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2021 $636,992,000 -$544,285,000 -587% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2020 $92,707,000 +$90,492,000 +49% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $183,199,000 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.